Patent 11706177 was granted and assigned to Salk Institute for Biological Studies on July, 2023 by the United States Patent and Trademark Office.
Provided herein are CRISPR/Cas methods and compositions for targeting RNA molecules, which can be used to detect, edit, or modify a target RNA.